II. Indications
- Alzheimer's Disease related Dementia
III. Contraindications
- Severe hepatic dysfunction (Child-Pugh >9)
- GFR <9 ml/min
IV. Mechanism
- Competitive and Reversible Acetylcholinesterase Inhibitor
- Acts also at Nicotinic Receptors
- Derived from Daffodil bulbs
V. Pharmacokinetics
VI. Medications
- Galantamine
- Tabs: 4, 8, 12 mg
- XR caps: 8, 16, 24 mg
- Oral Solution: 4 mg/ml
- Benzgalantamine (Zunveyl)
- Delayed Release Tablets: 5 mg, 10 mg, 15 mg
- New Galantamine prodrug due for release in 2025
- Twice daily delayed release agent with fewer gastrointestinal adverse effects, but at $800/month
- Contrast with extended release Galantamine ($30/month)
- Most of efficacy and safety data is extrapolated from Galantamine data
- (2025) Presc Lett 32(7): 41
VII. Dosing: Galantamine
- May require concurrent Antiemetic use
- Immediate Release
- Start: 4 mg orally twice daily with breakfast and dinner for 4 weeks
- Maintenance: 8 mg orally twice daily for at least 4 weeks
- Consider increase to 12 mg orally twice daily if indicated
- Extended Release
- Start: 8 mg orally daily for 4 weeks
- Maintenance: 16 mg orally daily for at least 4 weeks
- Consider increase to 24 mg orally daily if indicated
-
Renal Dosing
- GFR 9 to 59 ml/min: Maximum dose 16 mg/day
- GFR <9 ml/min: Avoid Galantamine
VIII. Dosing: Benzgalantamine (Zunveyl)
- Start: 5 mg orally twice daily swallowed whole without crushing, chewing or splitting
- May be taken with or without food
- Increase as needed to 10 mg orally twice daily after 4 weeks
- Maximum dose
- Normal renal and hepatic function: 15 mg orally twice daily
- Moderate liver disease (Child-Pugh 7-9) or GFR 10-60 ml/min: 10 mg orally twice daily
- GFR <9 ml/min: Avoid Benzgalantamine
IX. Adverse Effects
- See Acetylcholinesterase Inhibitor
- Cardiovascular
- Gastrointestinal
- Diarrhea
- Nausea (21%) or Vomiting (11%)
- Decreased appetite and Weight loss
- Increased gastric acid secretion (may increase risk of Peptic Ulcer Disease)
- Genitourinary
- Neuropsychiatric
- Serious skin reactions (<1% of patients)
X. Safety
- Monitor renal and hepatic function at baseline and with clinical change
XI. Efficacy
- Moderately preserved cognitive function for >6 months
- References
XII. Resources
- Galantamine (DailyMed)
- Benzgalantamine (DailyMed)
XIII. References
- Johnston (2025) Am Fam Physician
- (2001) Med Lett Drugs Ther 43(1107):53-4 [PubMed]
- Epperly (2017) Am Fam Physician 95(12): 771-8 [PubMed]
Images: Related links to external sites (from Bing)
Related Studies
galantamine (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
GALANTAMINE ER 16 MG CAPSULE | Generic | $1.66 each |
GALANTAMINE ER 24 MG CAPSULE | Generic | $1.17 each |
GALANTAMINE ER 8 MG CAPSULE | Generic | $1.11 each |
GALANTAMINE HBR 12 MG TABLET | Generic | $0.44 each |
GALANTAMINE HBR 4 MG TABLET | Generic | $0.34 each |
GALANTAMINE HBR 8 MG TABLET | Generic | $0.66 each |